A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

NCT06897202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity in Diabetes
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: MET097 Injection
DRUG: Placebo

Sponsor

Metsera, a wholly owned subsidiary of Pfizer